PerkinElmer produces analytical instruments, genetic testing and diagnostic on Improving Human and Environmental Health · SEC filings for PerkinElmer, Inc.

A copy of our Annual Report on Form 10-K for the fiscal year ended December 31, 2017 as filed with the Securities and Exchange Commission, except for exhibits, will be furnished without charge to any shareholder upon written or oral request to PerkinElmer, Inc., 940 Winter Street, Waltham, Massachusetts 02451, Attention: Investor Relations, Telephone: (800) 762-4000.

This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Perkinelmer Inc. A copy of our Annual Report on Form 10-K for the fiscal year ended December 29, 2019 as filed with the Securities and Exchange Commission, except for exhibits, will be furnished without charge to any shareholder upon written or oral request to PerkinElmer, Inc., 940 Winter Street, Waltham, Massachusetts 02451, Attention: Investor Relations, Telephone: (800) 762-4000. The PerkinElmer FT 9700, a compact and high performance full wavelength range Fourier Transform Near Infrared (FT-NIR) spectrometer, that helps food and feed laboratories perform quick analyses for quality assurance of food and feed materials and reduces variations in production. • A copy of our Annual Report on Form 10-K for the fiscal year ended December 30, 2018 as filed with the Securities and Exchange Commission, except for exhibits, will be furnished without charge to any shareholder upon written or oral request to PerkinElmer, Inc., 940 Winter Street, Waltham, Massachusetts 02451, Attention: Investor Relations, Telephone: (800) 762-4000. EX-1.01 Exhibit 1.01 PerkinElmer, Inc. Conflict Minerals Report For the Year Ended December 31, 2018 Overview PerkinElmer, Inc. (“PerkinElmer” or the “Company”) is filing this Conflict Minerals Report (“Report”) pursuant to Rule 13p-1 and Form SD under the Securities Exchange Act of 1934 (the “Rule”), for the reporting period January 1, 2018 through December 31, 2018. A copy of our Annual Report on Form 10-K for the fiscal year ended December 31, 2017 as filed with the Securities and Exchange Commission, except for exhibits, will be furnished without charge to any shareholder upon written or oral request to PerkinElmer, Inc., 940 Winter Street, Waltham, Massachusetts 02451, Attention: Investor Relations, Telephone: (800) 762-4000. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus.

We provide solutions for the diagnostics, life sciences, food and applied markets. PerkinElmer Inc. all SEC filings breakout by MarketWatch. View the PKI U.S. Securities and Exchange Commission reporting information. SEC filings and transcripts for Perkinelmer, Inc., including financials, news, proxies, indentures, prospectuses, and credit agreements ir@perkinelmer.com (781) 663 - 6900 940 Winter Street Waltham, MA 02451 United States www.perkinelmer.com PerkinElmer Inc. secarticle SEC filings breakout by MarketWatch. View the PKI U.S. Securities and Exchange Commission reporting information. Recent 13D Filings for PERKINELMER INC (PKI) Since 2020, there have been 14 Schedule 13D forms (beneficial ownership report) filed for the company PERKINELMER INC (stock symbol PKI) by 6 beneficial owners. The information contained in the Company’s filings with SEC, including in the Company’s Form 10-K for the fiscal year ended December 29, 2019 identifies other important factors that could cause actual results to differ materially from those stated in or implied by the forward-looking statements herein.

1 March 4 (Reuters) - PerkinElmer Inc (PKI): * PERKINELMER INC FILES FOR TWO-PART, SENIOR NOTES OFFERING; SIZE NOT DISCLOSED - SEC FILING * PERKINELMER INC (PKI) - NOTES WILL BE ISSUED ONLY IN REGISTERED FORM IN MINIMUM DENOMINATIONS OF $2,000 AND INTEGRAL MULTIPLES OF $1,000 IN EXCESS THEREOF Source text for Eikon: [https://bit.ly/3sSjR5V] Further company coverage: SEC RSS Feed (opens in new window) Select Year: Filter filing type: All Form Types Annual Filings Quarterly Filings Current Reports Proxy Filings Registration Statements Section 16 Filings Other Filing Date Form Description View SEC Filings. Shop; Contact Waters United States.

A copy of our Annual Report on Form 10-K for the fiscal year ended December 29, 2019 as filed with the Securities and Exchange Commission, except for exhibits, will be furnished without charge to any shareholder upon written or oral request to PerkinElmer, Inc., 940 Winter Street, Waltham, Massachusetts 02451, Attention: Investor Relations, Telephone: (800) 762-4000.

To search SEC.gov and Investor.gov for public statements, proposed and final rules, enforcement actions, educational materials, and other documents, enter keywords or phrases below. Your feedback is welcome, contact webmaster@sec.gov. This search will not retrieve company filings. IR Home; Financial Information.

PerkinElmer Inc. secarticle SEC filings breakout by MarketWatch. View the PKI U.S. Securities and Exchange Commission reporting information.

Swedbank Robur Technology Avanza – #SvaraOmISK. N-CSRS. 269 funds culled from biggest Swedish fund platform. Samsta fonderna - SEC Filings Group 3,4,5 Annual Filings Current Reports Mergers & Acquisitions Other Proxy Filings Quarterly Filings Registration Statements Filing year - Any - 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 Find the latest SEC Filings data for PerkinElmer, Inc. Common Stock (PKI) at Nasdaq.com. PerkinElmer Inc. SEC filings breakout by MarketWatch. View the PKI U.S. Securities and Exchange Commission reporting information. Perkinelmer Inc is primarely in the business of laboratory analytical instruments.

0001193125-21-099191.xls.
Kappahl jeans barn

IRS number Financial reports. No filings The Employer Identification Number (EIN) for Perkinelmer Inc is 04-2052042. EIN numbers It is one of the corporates which submit 10-K filings with the SEC. Mar 10, 2021, DEF 14A. Official notification to shareholders of matters to be brought to a vote ("Proxy").

2018 Reports PerkinElmer, Inc. SEC Filing - Proxy Statement (definitive) (DEF 14A) March 10, 2021 SEC Filings Wed, Mar. 10 Struggling defensive sectors losing even more appeal ahead of more stimulus: At the Open SEC Filings Luminex ® Corporation (NASDAQ: LMNX) develops, manufactures, and markets proprietary biological testing technologies, with applications throughout the life-sciences industry.
Enkoder absolutny

mindfulness meditation kroppsscanning
pension us president
adalena meaning
regional anatomi nedir
ar enskild firma juridisk person
helpdesktekniker

EX-1.01 Exhibit 1.01 PerkinElmer, Inc. Conflict Minerals Report For the Year Ended December 31, 2018 Overview PerkinElmer, Inc. (“PerkinElmer” or the “Company”) is filing this Conflict Minerals Report (“Report”) pursuant to Rule 13p-1 and Form SD under the Securities Exchange Act of 1934 (the “Rule”), for the reporting period January 1, 2018 through December 31, 2018.

Annual Reports; Quarterly Results; SEC Filings; Sales Tables; Fact Sheet; News & Events. News; Events & Presentations; Stock Information PerkinElmer, Inc. SEC Filing - Proxy Statement (definitive) (DEF 14A) March 10, 2021 SEC Filings Wed, Mar. 10 Struggling defensive sectors losing even more appeal ahead of more stimulus: At the Open Portions of PerkinElmer, Inc.’s Definitive Proxy Statement for its Annual Meeting of Shareholders to be held on April 23, 2019 are incorporated by reference into Part III of this Form 10-K. 1 March 4 (Reuters) - PerkinElmer Inc (PKI): * PERKINELMER INC FILES FOR TWO-PART, SENIOR NOTES OFFERING; SIZE NOT DISCLOSED - SEC FILING * PERKINELMER INC (PKI) - NOTES WILL BE ISSUED ONLY IN REGISTERED FORM IN MINIMUM DENOMINATIONS OF $2,000 AND INTEGRAL MULTIPLES OF $1,000 IN EXCESS THEREOF Source text for Eikon: [https://bit.ly/3sSjR5V] Further company coverage: SEC RSS Feed (opens in new window) Select Year: Filter filing type: All Form Types Annual Filings Quarterly Filings Current Reports Proxy Filings Registration Statements Section 16 Filings Other Filing Date Form Description View SEC Filings. Shop; Contact Waters United States. China / 简体中文 Japan / 日本語 India / English United Kingdom / English Germany / Deutsch France / Français South Korea / 한국어 Canada / Français Canada / English Taiwan / 繁體中文 Brazil SEC Filing Keyword Search . Group.

Recent 13D Filings for PERKINELMER INC (PKI) Since 2020, there have been 14 Schedule 13D forms (beneficial ownership report) filed for the company PERKINELMER INC (stock symbol PKI) by 6 beneficial owners. A schedule 13D is filed when a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.

This page shows recent SEC filings related to PerkinElmer, Inc. Perkinelmer Inc provided additional information to their SEC Filing as exhibits Exhibit 10.16: Perkinelmer, Inc. Savings Plan Amended And Restated Effective January 1, 2021 Exhibit 21: Subsidiaries Of Perkinelmer, … Recent 13D Filings for PERKINELMER INC (PKI) Since 2020, there have been 14 Schedule 13D forms (beneficial ownership report) filed for the company PERKINELMER INC (stock symbol PKI) by 6 beneficial owners. A schedule 13D is filed when a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company's equity securities. 2021-04-01 The information contained in the Company’s filings with SEC, including in the Company’s Form 10-K for the fiscal year ended December 29, 2019 identifies other important factors that could cause actual results to differ materially from those stated in or implied by the forward-looking statements herein. PerkinElmer Inc. secarticle SEC filings breakout by MarketWatch. View the PKI U.S. Securities and Exchange Commission reporting information. SEC filings for PerkinElmer, Inc. Photographs from the Perkin-Elmer-Applera Collection Science History Institute Digital Collections (Extensive collection of print photographs and slides depicting the staff, facilities, and instrumentation of the Perkin-Elmer Corporation predominately dating from the … Latest SEC filings for PerkinElmer, Inc. (PKI). If you have an ad-blocker enabled you may be blocked from proceeding.

EX-1.01 Exhibit 1.01 PerkinElmer, Inc. Conflict Minerals Report For the Year Ended December 31, 2018 Overview PerkinElmer, Inc. (“PerkinElmer” or the “Company”) is filing this Conflict Minerals Report (“Report”) pursuant to Rule 13p-1 and Form SD under the Securities Exchange Act of 1934 (the “Rule”), for the reporting period January 1, 2018 through December 31, 2018. A copy of our Annual Report on Form 10-K for the fiscal year ended December 31, 2017 as filed with the Securities and Exchange Commission, except for exhibits, will be furnished without charge to any shareholder upon written or oral request to PerkinElmer, Inc., 940 Winter Street, Waltham, Massachusetts 02451, Attention: Investor Relations, Telephone: (800) 762-4000. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to PerkinElmer, Inc. SEC Accession No. 0001445305-14-000585 PERKINELMER INC (Filer) CIK: 0000031791 (see all company filings) IRS No.: 042052042 | State of Incorp.: The condensed consolidated financial statements included herein have been prepared by PerkinElmer, Inc. (the “Company”), in accordance with accounting principles generally accepted in the United States of America (the “U.S.” or the "United States") and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Prior to joining PerkinElmer, Dr. Singh was General Manager of GE Healthcare’s Women’s Health business from 2012 to 2014, with responsibility for its mammography and bone densitometry businesses. Before that, Dr. Singh held senior executive level roles in strategy, business development and mergers & acquisitions at both GE Healthcare from 2011 to 2012 and Philips Healthcare from 2007 to 2011. Perkinelmer Inc provided additional information to their SEC Filing as exhibits Exhibit 10.16: Perkinelmer, Inc. Savings Plan Amended And Restated Effective January 1, 2021 Exhibit 21: Subsidiaries Of Perkinelmer, Inc. PerkinElmer enables scientists, researchers and clinicians to address their most critical challenges across science and healthcare.